108 related articles for article (PubMed ID: 34593462)
1. The Role of Serum Tumor Markers in Follow-up After Surgical Treatment of Malignant Lung Tumors.
Vodicka J; Skala M; Sebek J; Treska V; Fichtl J; Prochazkova K; Vankova B; Svaton M; Pecen L; Topolcan O; Bludovska M; Kucera R
Anticancer Res; 2021 Oct; 41(10):5117-5122. PubMed ID: 34593462
[TBL] [Abstract][Full Text] [Related]
2. Preoperative AminoIndex Cancer Screening (AICS) abnormalities predict postoperative recurrence in patients undergoing curative resection for non-small cell lung cancer.
Higashiyama M; Miyazaki R; Yamamoto H; Anayama T; Kikuchi S; Hirohashi K; Okami J; Maniwa T; Kimura T; Orihashi K; Imamura F
BMC Cancer; 2020 Nov; 20(1):1100. PubMed ID: 33183251
[TBL] [Abstract][Full Text] [Related]
3. Kynurenine/Tryptophan Ratio as a Potential Blood-Based Biomarker in Non-Small Cell Lung Cancer.
Mandarano M; Orecchini E; Bellezza G; Vannucci J; Ludovini V; Baglivo S; Tofanetti FR; Chiari R; Loreti E; Puma F; Sidoni A; Belladonna ML
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922388
[TBL] [Abstract][Full Text] [Related]
4. Association between serum biomarkers CEA and LDH and response in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.
de Jong C; Deneer VHM; Kelder JC; Ruven H; Egberts TCG; Herder GJM
Thorac Cancer; 2020 Jul; 11(7):1790-1800. PubMed ID: 32383328
[TBL] [Abstract][Full Text] [Related]
5. The preoperative platelet distribution width: A predictive factor of the prognosis in patients with non-small cell lung cancer.
Liu C; Zhang H; Qi Q; Zhang B; Yue D; Wang C
Thorac Cancer; 2020 Apr; 11(4):918-927. PubMed ID: 32061027
[TBL] [Abstract][Full Text] [Related]
6. [Clinical and prognostic significance of tumor markers cytokeratin 19 fragment, carcinoembryonic antigen, and neuron-specific enolase in lung cancer].
Zemaitis M; Sakalauskas R; Malakauskas K; Muley T; Fischer JR; Lahm H
Medicina (Kaunas); 2005; 41(7):566-76. PubMed ID: 16062024
[TBL] [Abstract][Full Text] [Related]
7. Association of preoperative serum CRP with PD-L1 expression in 508 patients with non-small cell lung cancer: A comprehensive analysis of systemic inflammatory markers.
Akamine T; Takada K; Toyokawa G; Kinoshita F; Matsubara T; Kozuma Y; Haratake N; Takamori S; Hirai F; Tagawa T; Okamoto T; Yoneshima Y; Okamoto I; Shimokawa M; Oda Y; Nakanishi Y; Maehara Y
Surg Oncol; 2018 Mar; 27(1):88-94. PubMed ID: 29549910
[TBL] [Abstract][Full Text] [Related]
8. The clinical significance of CXCL16 in the treatment of advanced non-small cell lung cancer.
Shibata Y; Kobayashi N; Sato T; Nakashima K; Kaneko T
Thorac Cancer; 2020 May; 11(5):1258-1264. PubMed ID: 32163231
[TBL] [Abstract][Full Text] [Related]
9. Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role.
Wieskopf B; Demangeat C; Purohit A; Stenger R; Gries P; Kreisman H; Quoix E
Chest; 1995 Jul; 108(1):163-9. PubMed ID: 7541742
[TBL] [Abstract][Full Text] [Related]
10. Stable and discriminating radiomic predictor of recurrence in early stage non-small cell lung cancer: Multi-site study.
Khorrami M; Bera K; Leo P; Vaidya P; Patil P; Thawani R; Velu P; Rajiah P; Alilou M; Choi H; Feldman MD; Gilkeson RC; Linden P; Fu P; Pass H; Velcheti V; Madabhushi A
Lung Cancer; 2020 Apr; 142():90-97. PubMed ID: 32120229
[TBL] [Abstract][Full Text] [Related]
11. Clinical usefulness of serum cytokeratin 19 fragment as a tumor marker for lung cancer.
Maeda Y; Segawa Y; Takigawa N; Takata I; Fujimoto N
Intern Med; 1996 Oct; 35(10):764-71. PubMed ID: 8933183
[TBL] [Abstract][Full Text] [Related]
12. Poor prognosis of NSCLC located in lower lobe is partly mediated by lower frequency of EGFR mutations.
Lee HW; Park YS; Park S; Lee CH
Sci Rep; 2020 Sep; 10(1):14933. PubMed ID: 32913267
[TBL] [Abstract][Full Text] [Related]
13. Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multicentre study.
Ebert W; Dienemann H; Fateh-Moghadam A; Scheulen M; Konietzko N; Schleich T; Bombardieri E
Eur J Clin Chem Clin Biochem; 1994 Mar; 32(3):189-99. PubMed ID: 7518259
[TBL] [Abstract][Full Text] [Related]
14. Subunit-specific mass spectrometry method identifies haptoglobin subunit alpha as a diagnostic marker in non-small cell lung cancer.
Park J; Yang JS; Jung G; Woo HI; Park HD; Kim JW; Huh W; Ko JW; Kim H; Cho JY; Lee SY
J Proteomics; 2013 Dec; 94():302-10. PubMed ID: 24120528
[TBL] [Abstract][Full Text] [Related]
15. Combined detection of estrogen and tumor markers is an important reference factor in the diagnosis and prognosis of lung cancer.
Bai Y; Shen W; Zhu M; Zhang L; Wei Y; Tang H; Zhao J
J Cell Biochem; 2019 Jan; 120(1):105-114. PubMed ID: 30216488
[TBL] [Abstract][Full Text] [Related]
16. Survival disparities following surgery among patients with different histological types of non-small cell lung cancer.
Grosu HB; Manzanera A; Shivakumar S; Sun S; Noguras Gonzalez G; Ost DE
Lung Cancer; 2020 Feb; 140():55-58. PubMed ID: 31865279
[TBL] [Abstract][Full Text] [Related]
17. The clinical role of VeriStrat testing in patients with advanced non-small cell lung cancer considered unfit for first-line platinum-based chemotherapy.
Lee SM; Upadhyay S; Lewanski C; Falk S; Skailes G; Woll PJ; Hatton M; Lal R; Jones R; Toy E; Rudd R; Ngai Y; Edwards A; Hackshaw A
Eur J Cancer; 2019 Oct; 120():86-96. PubMed ID: 31499384
[TBL] [Abstract][Full Text] [Related]
18. Lactate dehydrogenase and serum tumor markers for predicting metastatic status in geriatric patients with lung adenocarcinoma.
Ren X; Zhang Y; Lyu Y; Jin B; Guo H; Wu J; Li X; Liu X
Cancer Biomark; 2019; 26(2):139-150. PubMed ID: 31356196
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement.
Inoue M; Minami M; Shiono H; Sawabata N; Ideguchi K; Okumura M
J Thorac Cardiovasc Surg; 2006 May; 131(5):988-93. PubMed ID: 16678580
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of perioperative serum carcinoembryonic antigen in non-small cell lung cancer: analysis of 1,000 consecutive resections for clinical stage I disease.
Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
Ann Thorac Surg; 2004 Jul; 78(1):216-21. PubMed ID: 15223432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]